Franklin BSP Realty Trust, Inc. (FBRT) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Franklin BSP Realty Trust, Inc. is a Maryland corporation taxed as a Real Estate Investment Trust (REIT) that originates, acquires, and manages a diversified portfolio of commercial real estate debt investments. The company is externally managed by Benefit Street Partners L.L.C. (the "Advisor"), a subsidiary of Franklin Resources, Inc. The portfolio primarily consists of commercial mortgage loans, real estate securities, and real estate owned (REO) assets acquired through foreclosure or purchase.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | Q2 2023 (3 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Interest Income | $46.8 million | $96.1 million | $77.6 million | $137.1 million |
| Total Income | $50.9 million | $104.8 million | $84.0 million | $146.8 million |
| Net Income (Loss) | $(3.8) million | $32.1 million | $39.6 million | $83.5 million |
| Net Income Attributable to Common | $(8.9) million | $20.2 million | $32.9 million | $69.9 million |
| Diluted EPS | $(0.11) | $0.24 | $0.39 | $0.83 |
| Provision for Credit Losses | $32.2 million | $35.1 million | $21.6 million | $26.0 million |
| Total Assets | $6.27 billion | As of June 30, 2024 | ||
| Total Liabilities | $4.64 billion | As of June 30, 2024 | ||
| Stockholders' Equity | $1.52 billion | As of June 30, 2024 | ||
| Cash & Cash Equivalents | $94.8 million | As of June 30, 2024 | ||
| Book Value Per Share | $15.18 | As of June 30, 2024 |
Material Changes vs. Prior Period
- Net Income Decline: The company reported a net loss of $3.8 million for Q2 2024, compared to net income of $39.6 million in Q2 2023. This was primarily driven by a significant increase in the provision for credit losses ($32.2 million in Q2 2024 vs. $21.6 million in Q2 2023) and a decrease in net interest income.
- Credit Loss Provisions: The increase in credit loss provisions was largely due to specific reserves on non-performing loans, including a non-performing office loan in Colorado placed on cost recovery status. The total allowance for credit losses increased to $80.5 million from $47.2 million at year-end 2023.
- Net Interest Income Compression: Net interest income decreased by $30.8 million year-over-year. This was caused by an increase in non-accrual loans (totaling $225.4 million in principal) and higher interest expense due to increased balances in collateralized loan obligations (CLOs) and higher financing costs.
- Real Estate Owned (REO) Losses: The company recorded a $6.2 million loss on other real estate investments, primarily due to write-downs and sales related to the Walgreens Portfolio and the onboarding of multifamily properties acquired through foreclosure.
- Liquidity Position: Cash and cash equivalents decreased significantly from $337.6 million at December 31, 2023, to $94.8 million at June 30, 2024, reflecting active deployment of capital into new loan originations ($1.1 billion in the first six months).
Guidance, Outlook, and Risks
- Outlook: Management expects to continue operating at a leverage level between one to three times book value of equity. The company maintains an effective shelf registration for equity offerings and an at-the-market (ATM) program for up to $200 million, though no shares have been sold under the ATM to date.
- Share Repurchases: The company has a $65 million share repurchase program. As of June 30, 2024, $31.1 million remained available. The company repurchased 240,740 shares in Q2 2024 at an average price of $12.42 per share.
- Dividends: The board declared a quarterly common dividend of $0.355 per share. The company intends to maintain its REIT qualification by distributing at least 90% of taxable income.
- Risks:
- Credit Risk: Exposure to loan defaults, particularly in the office and multifamily sectors, leading to increased non-performing assets and credit loss provisions.
- Liquidity Risk: Reliance on repurchase agreements and CLOs; margin calls could arise if collateral values decline.
- Interest Rate Risk: While the portfolio is largely floating-rate (SOFR), rising rates increase borrowing costs. A 100 basis point increase in rates is estimated to increase net interest income by 5.55%.
- Real Estate Risk: Volatility in property values affecting collateral and REO asset realizations.
- Unusual Items: The Q2 results were impacted by specific credit loss provisions on non-performing loans and losses on the Walgreens Portfolio. A subsequent event noted the sale of 16 Walgreens properties on July 1, 2024, for $60.9 million.
Investor Verification Checklist
- Credit Quality Trends: Verify the trajectory of non-performing loans (currently $225.0 million amortized cost) and the adequacy of the $80.5 million allowance for credit losses.
- REO Realization: Monitor the sale progress and pricing of the Walgreens Portfolio and newly acquired multifamily properties classified as "held for sale" ($271.3 million carrying value).
- Liquidity Runway: Assess the sustainability of the $94.8 million cash balance against upcoming debt maturities and distribution obligations ($36.2 million payable).
- Financing Costs: Review the weighted average interest rate on liabilities (7.8% for Q2 2024) and the impact of rising SOFR on net interest margins.
- Non-GAAP Measures: Compare GAAP Net Income to Distributable Earnings ($32.4 million for Q2 2024) to understand the impact of non-cash credit reserves on reported earnings.